Elgadi Aziz, Verbovszki Petra, Marcus Claude, Berg Ulla B
Department of Clinical Science, Intervention and Technology, Division of Pediatrics, Karolinska Institutet, Huddinge, Stockholm, Sweden.
J Pediatr. 2008 Jun;152(6):860-4. doi: 10.1016/j.jpeds.2007.10.050. Epub 2007 Dec 26.
To examine the impact of hypothyroidism on renal function in children and the effect of thyroid hormone therapy on the long-term outcome.
The glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) were studied in 31 patients with symptomatic acquired hypothyroidism (age, 11 +/- 3.3 years) and in 50 healthy children (age, 10.5 +/- 4.5 years). Children with hypothyroidism were examined before starting thyroxine therapy and 1 week and 1, 3, and 6 months after starting thyroxine therapy. 13 patients were reinvestigated at 6, 12, 18, 36, and 60 months after initiating thyroxine therapy.
GFR and ERPF were <-2 SD of control levels in 58% and 45%, respectively, of children investigated before or within 1 week after starting thyroxine therapy. 31% and 6% of the children studied 1 to 6 months after thyroxine therapy had a GFR and ERPF <-2 SD. Moreover, when GFR and ERPF values were analyzed as percent of control mean, both measurements were reduced to an equal extent. At the last investigation, 1 to 5 years after start of treatment, the GFR was still significantly lower in children with hypothyroidism than that in control subjects.
Acquired hypothyroidism during childhood may have a long-term impact on renal function.
研究甲状腺功能减退对儿童肾功能的影响以及甲状腺激素治疗对长期预后的作用。
对31例有症状的获得性甲状腺功能减退患儿(年龄11±3.3岁)和50名健康儿童(年龄10.5±4.5岁)进行肾小球滤过率(GFR)和有效肾血浆流量(ERPF)研究。甲状腺功能减退患儿在开始甲状腺素治疗前、治疗开始后1周、1、3和6个月进行检查。13例患儿在开始甲状腺素治疗后6、12、18、36和60个月再次接受检查。
在开始甲状腺素治疗前或治疗后1周内接受检查的患儿中,分别有58%和45%的患儿GFR和ERPF低于对照水平的-2标准差。在甲状腺素治疗后1至6个月接受研究的患儿中,分别有31%和6%的患儿GFR和ERPF低于-2标准差。此外,当将GFR和ERPF值作为对照平均值的百分比进行分析时,两项测量值下降程度相同。在治疗开始后1至5年的最后一次检查中,甲状腺功能减退患儿的GFR仍显著低于对照受试者。
儿童期获得性甲状腺功能减退可能对肾功能产生长期影响。